Literature DB >> 24575439

Why the Cochrane risk of bias tool should include funding source as a standard item.

Lisa A Bero1.   

Abstract

Mesh：

Year:  2013        PMID： 24575439     DOI： 10.1002/14651858.ED000075

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  36 in total

Review 1.  The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.

Authors:  L Bero; A Anglemyer; H Vesterinen; D Krauth
Journal:  Environ Int       Date:  2015-12-13       Impact factor: 9.621

Review 2.  Systematic review of community health impacts of mountaintop removal mining.

Authors:  Abee L Boyles; Robyn B Blain; Johanna R Rochester; Raghavendhran Avanasi; Susan B Goldhaber; Sofie McComb; Stephanie D Holmgren; Scott A Masten; Kristina A Thayer
Journal:  Environ Int       Date:  2017-07-21       Impact factor: 9.621

Review 3.  Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Ramin Zand; Vijay K Sharma; Martin Köhrmann; Sotirios Giannopoulos; Efthymios Dardiotis; Anne W Alexandrov; Panayiotis D Mitsias; Peter D Schellinger; Andrei V Alexandrov
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

4.  The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed.

Authors:  Ole Jakob Storebø; Erik Simonsen; Christian Gluud
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04-30       Impact factor: 4.785

5.  How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards.

Authors:  Andrew A Rooney; Glinda S Cooper; Gloria D Jahnke; Juleen Lam; Rebecca L Morgan; Abee L Boyles; Jennifer M Ratcliffe; Andrew D Kraft; Holger J Schünemann; Pamela Schwingl; Teneille D Walker; Kristina A Thayer; Ruth M Lunn
Journal:  Environ Int       Date:  2016-02-06       Impact factor: 9.621

6.  Response to correspondence by Heather Lynch, Julie Goodman and Nancy Beck Re: "Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan".

Authors:  Paula I Johnson; Patrice Sutton; Erica Koustas; Hanna M Vesterinen; Tracey J Woodruff
Journal:  Environ Int       Date:  2017-02-21       Impact factor: 9.621

Review 7.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

8.  The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Ioannis Heliopoulos; Panagiotis Papathanasopoulos; Efthimios Dardiotis; Constantinos Kilidireas; Konstantinos Voumvourakis
Journal:  Ther Adv Neurol Disord       Date:  2015-09       Impact factor: 6.570

Review 9.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

10.  Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.

Authors:  Uwe Matterne; Merle Margarete Böhmer; Elke Weisshaar; Aldrin Jupiter; Ben Carter; Christian J Apfelbacher
Journal:  Cochrane Database Syst Rev       Date:  2019-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.